Tudor Investment Corp’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.95M	Sell	120,122 -70,007	-37%	-$1.24M	0.01%	1877
2025 Q4	$3.56M	Buy	190,129 +139,081	+272%	+$2.31M	0.02%	1377
2025 Q3	$745K	Sell	51,048 -145,515	-74%	-$1.84M	﹤0.01%	2466
2025 Q2	$2.17M	Sell	196,563 -10	-0%	-$97	0.02%	1610
2025 Q1	$1.76M	Sell	196,573 -5	-0%	-$47	0.02%	1439
2024 Q4	$1.85M	Hold	196,578	–	–	0.02%	1315
2024 Q3	$1.58M	Buy	196,578 +2,810	+1%	+$24.3K	0.02%	1345
2024 Q2	$1.64M	Buy	193,768 +16,156	+9%	+$146K	0.02%	1183
2024 Q1	$1.59M	Buy	177,612 +167,529	+1,661%	+$1.55M	0.02%	1128
2023 Q4	$113K	Sell	10,083 -97,665	-91%	-$983K	﹤0.01%	2242
2023 Q3	$930K	Sell	107,748 -13,918	-11%	-$134K	0.01%	1339
2023 Q2	$1.26M	Buy	121,666 +13,031	+12%	+$144K	0.02%	1177
2023 Q1	$1.18M	Buy	108,635 +15,201	+16%	+$161K	0.02%	1097
2022 Q4	$1.05M	Buy	+93,434	New	+$982K	0.03%	1074
2022 Q3	–	Sell	-103,280	Closed	-$936K	–	2825
2022 Q2	$936K	Buy	103,280 +71,364	+224%	+$658K	0.03%	931
2022 Q1	$305K	Sell	31,916 -141,498	-82%	-$1.39M	0.01%	1545
2021 Q4	$1.92M	Buy	173,414 +121,705	+235%	+$1.06M	0.04%	655
2021 Q3	$383K	Buy	+51,709	New	+$578K	0.01%	1846
2015 Q3	–	Sell	-27,800	Closed	-$362K	–	1750
2015 Q2	$362K	Buy	+27,800	New	+$431K	0.01%	992